SUPPLEMENTARY INFORMATION

FROM:

The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer

J Tommiska, J Bartkova, M Heinonen, L Hautala, O Kilpivaara, H Eerola, K Aittomäki, B Hofstetter, J Lukas, K von Smitten, C Blomqvist, A Ristimäki, P Heikkilä, J Bartek and H Nevanlinna